Literature DB >> 18037187

Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver.

Fu Yang1, Shikai Yan, Ying He, Fang Wang, Shuxia Song, Yingjun Guo, Qi Zhou, Yue Wang, Zhongying Lin, Yun Yang, Weidong Zhang, Shuhan Sun.   

Abstract

BACKGROUND/AIMS: Hepatitis B virus transgenic mice (HBV-Tg mice) have been widely used as animal models in the study of pathogenesis and control of hepatitis B. It is important for the evaluation of such animal models to define the physiological differences between HBV-Tg and wild-type mice. The aim of this research was to investigate whether the integrated system biology approach that combines proteomics and metabonomics describes the physiological changes and provides new insights into the pathogenesis of the early stages of HBV infection.
METHODS: In this study the protein and metabolite profiles of the liver were established based on two-dimensional electrophoresis and HPLC/MS analysis.
RESULTS: Several protein molecules, whose expression was altered in HBV-Tg mouse liver, were identified including protective enzymes against oxidative stress and regulatory proteins related to lipid metabolism. Metabonomics confirmed the potential derangement of lipid metabolism by discovering the intermediate and the final products of lipid metabolism that were markedly changed in transgenic mice.
CONCLUSIONS: This study demonstrated that HBV antigens could impair host cell lipid metabolism and induce modest oxidative stress in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037187     DOI: 10.1016/j.jhep.2007.06.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  XCMS Online: a web-based platform to process untargeted metabolomic data.

Authors:  Ralf Tautenhahn; Gary J Patti; Duane Rinehart; Gary Siuzdak
Journal:  Anal Chem       Date:  2012-05-10       Impact factor: 6.986

Review 2.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Host acyl coenzyme A binding protein regulates replication complex assembly and activity of a positive-strand RNA virus.

Authors:  Jiantao Zhang; Arturo Diaz; Lan Mao; Paul Ahlquist; Xiaofeng Wang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 4.  Hydrogen sulfide and hepatic lipid metabolism - a critical pairing for liver health.

Authors:  Julie J Loiselle; Guangdong Yang; Lingyun Wu
Journal:  Br J Pharmacol       Date:  2018-12-28       Impact factor: 8.739

Review 5.  Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.

Authors:  Chu-wen Lin; Xiao-li Huang; Hai-lin Liu; Yan Wang
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

Review 6.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

7.  A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways.

Authors:  R Jason Lamontagne; Jessica C Casciano; Michael J Bouchard
Journal:  Metabolism       Date:  2018-02-02       Impact factor: 8.694

Review 8.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

9.  The action of D-dopachrome tautomerase as an adipokine in adipocyte lipid metabolism.

Authors:  Takeo Iwata; Hisaaki Taniguchi; Masamichi Kuwajima; Takako Taniguchi; Yuko Okuda; Akiko Sukeno; Kyoko Ishimoto; Noriko Mizusawa; Katsuhiko Yoshimoto
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

10.  Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus.

Authors:  Yan Ma; Jun Yu; Henry L Y Chan; Yang-chao Chen; Hua Wang; Ying Chen; Chu-yan Chan; Minnie Y Y Go; Sau-na Tsai; Sai-ming Ngai; Ka-fai To; Joanna H M Tong; Qing-Yu He; Joseph J Y Sung; Hsiang-fu Kung; Christopher H K Cheng; Ming-liang He
Journal:  Mol Cell Proteomics       Date:  2009-08-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.